Assignee
GLYCART BIOTECHNOLOGY AG
CH·7 granted patents·2 pending applications·2,052 citations·filing 1999–2007
Top patents by PatentIndex Score
9 records- 0198US6602684B1Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicityGLYCART BIOTECHNOLOGY AG·Filed 1999·Granted Aug 5, 2003·1.8k cites·10 claims
- 0297US7517670B2Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicityGLYCART BIOTECHNOLOGY AG·Filed 2003·Granted Apr 14, 2009·83 cites·67 claims
- 0396US7722867B2Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereofGLYCART BIOTECHNOLOGY AG·Filed 2006·Granted May 25, 2010·33 cites·57 claims
- 0495US7906329B2Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicityGLYCART BIOTECHNOLOGY AG·Filed 2003·Granted Mar 15, 2011·50 cites·43 claims
- 0595US7846432B2Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereofGLYCART BIOTECHNOLOGY AG·Filed 2007·Granted Dec 7, 2010·20 cites·35 claims
- 0695US7727741B2Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereofGLYCART BIOTECHNOLOGY AG·Filed 2007·Granted Jun 1, 2010·26 cites·14 claims
- 0794US7662377B2Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereofGLYCART BIOTECHNOLOGY AG·Filed 2007·Granted Feb 16, 2010·21 cites·55 claims
- 0844US2006223096A1Antigen binding molecules directed to MCSP and having increased Fc receptor binding affinity and effector functionGLYCART BIOTECHNOLOGY AG·Filed 2006·Application pending·0 cites
- 0942US2007111281A1Antigen binding molecules having modified Fc regions and altered binding to Fc receptorsGLYCART BIOTECHNOLOGY AG·Filed 2006·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →